Literature DB >> 6173434

Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A.

B S Wang, E H Heacock, Z Chang-Xue, N L Tilney, T B Strom, J A Mannick.   

Abstract

Mice sensitized with alloantigens and treated with cyclosporin A (CsA) were incapable of generating antigen-specific cytolytic lymphocytes (CL). Lymphocytes from these CsA-treated animals could not be reactivated upon exposure to the same alloantigens in mixed lymphocyte culture (MLC), whereas their response to a third-party antigen remained intact, suggesting a long-lasting and specific effect of CsA. After being irradiated, these lymphocytes from CsA-treated animals were added to normal MLC and were shown to prevent normal lymphocytes from becoming cytolytic in a dose-dependent and antigen-nonspecific fashion. These suppressor cells were not detected in mice receiving CsA only, indicating that CsA did not induce but rather permitted the expression of suppressor cells possibly generated by allosensitization. The suppressor cells appeared to be T lymphocytes, because treatment with anti-Thy-1.2 antibody and C abrogated their suppressive activity. The present results suggest that activation and/or sparing of suppressor cells by CsA may account for the long-lasting unresponsiveness seen in CsA-treated animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173434

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation.

Authors:  P L Fidel; J W Murphy
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  2006 Homer W. Smith Lecture: taming T cells.

Authors:  Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

Review 3.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 4.  Immunosuppressive therapy for renal transplantation.

Authors:  C B Carpenter; T B Strom
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.

Authors:  M Estrin; C Smith; S Huber
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

6.  Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

Authors:  A A Like; V Dirodi; S Thomas; D L Guberski; A A Rossini
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.

Authors:  S A Bishop; T J Hill
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Mechanism of recovery from acute virus infection. II. Effect of treatment of mice with cyclosporin A on their ability to eliminate the lymphocytic choriomeningitis virus.

Authors:  C Löliger; F Lehmann-Grube
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

9.  Pathogenetic difference between collagen arthritis and adjuvant arthritis.

Authors:  N Kaibara; T Hotokebuchi; K Takagishi; I Katsuki; M Morinaga; C Arita; S Jingushi
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

10.  Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2.

Authors:  S Rich; M R Carpino; C Arhelger
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.